Production (Stage)
D
Telomir Pharmaceuticals, Inc. TELO
$2.10 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 10.75M 10.01M 8.25M 3.56M 3.44M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 12.57M 12.30M 10.48M 5.42M 5.38M
Operating Income -12.57M -12.30M -10.48M -5.42M -5.38M
Income Before Tax -12.52M -16.59M -23.02M -18.74M -18.84M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -12.52 -16.59 -23.02 -18.74 -18.84
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -12.52M -16.59M -23.02M -18.74M -18.84M
EBIT -12.57M -12.30M -10.48M -5.42M -5.38M
EBITDA -- -- -- -- --
EPS Basic -0.42 -0.57 -0.82 -0.68 -0.69
Normalized Basic EPS -0.26 -0.36 -0.34 -0.25 -0.26
EPS Diluted -0.42 -0.57 -0.82 -0.68 -0.69
Normalized Diluted EPS -0.26 -0.36 -0.34 -0.25 -0.26
Average Basic Shares Outstanding 118.64M 116.65M 114.09M 111.57M 109.06M
Average Diluted Shares Outstanding 118.64M 116.65M 114.09M 111.57M 109.06M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --